Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor Therapy

We report here a patient with stage IV mucosal melanoma treated with dual immune checkpoint inhibitor (ICI) therapy (Nivolumab/Ipilimumab) who experienced rapid disease progression and metastatic spread within three weeks of first infusion. Surprisingly, this patient also developed fulminant myocard...

Descripción completa

Detalles Bibliográficos
Autores principales: Barham, Whitney, Guo, Ruifeng, Park, Sean S., Herrmann, Joerg, Dong, Haidong, Yan, Yiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884751/
https://www.ncbi.nlm.nih.gov/pubmed/33603731
http://dx.doi.org/10.3389/fimmu.2020.561083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884751/
https://www.ncbi.nlm.nih.gov/pubmed/33603731
http://dx.doi.org/10.3389/fimmu.2020.561083

Ejemplares similares